gene therapy biospace - Robuta Search

https://www.biospace.com/bayer-bolsters-cell-and-gene-therapy-platform-with-mammoth-deal-for-crispr-technology Bayer Strikes "Mammoth" CRISPR Deal to Bolster Cell and Gene Therapy - BioSpace Jan 10, 2022 - Bayer and Mammoth Biosciences forged a strategic collaboration potentially valued at more than $1 billion. The partnership grants Bayer access to Mammoth’s... gene therapy biospace bayer strikes mammoth crispr https://www.biospace.com/gene-therapy Gene therapy - BioSpace gene therapy biospace https://www.biospace.com/cell-and-gene-therapy Cell and Gene Therapy - BioSpace gene therapy biospace cell https://www.biospace.com/fda/why-industry-is-questioning-fdas-data-sharing-push-in-cell-and-gene-therapy Why Industry Is Questioning FDA’s Data-Sharing Push in Cell and Gene Therapy - BioSpace Mar 12, 2026 - After the FDA’s first-ever public listening meeting on data-sharing in the cell and gene therapy space, new draft guidance aims to standardize the practice.... gene therapy biospace data sharing industry questioning push https://www.biospace.com/business/weight-loss-drama-compounds-on-heels-of-novo-lilly-earnings-plus-gene-therapy-news Weight Loss Drama Compounds on Heels of Novo, Lilly Earnings, Plus Gene Therapy News - BioSpace gene therapy news weight loss drama compounds heels https://www.biospace.com/fda/intellias-crispr-gene-therapy-free-to-move-forward-after-fda-fully-lifts-hold Intellia’s CRISPR Gene Therapy Free To Move Forward After FDA Fully Lifts Hold - BioSpace Mar 3, 2026 - The FDA last October paused Intellia Therapeutics’ late-stage CRISPR studies after detecting life-threatening enzyme elevations in one patient, who died a few... crispr gene therapy free move forward fda fully https://www.biospace.com/policy/regenxbio-secures-legal-win-in-gene-therapy-patent-battle-vs-sarepta REGENXBIO Secures Legal Win in Gene Therapy Patent Battle Vs. Sarepta - BioSpace Feb 23, 2026 - A lower court had previously ruled for Sarepta in the companies’ long-running dispute, finding that REGENXBIO’s AAV patent was invalid because its elements... secures legal gene therapy patent battle regenxbio win https://www.biospace.com/business/rejuvenate-crowdfunds-development-of-gene-therapy-for-aging-chronic-diseases Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases - BioSpace Apr 27, 2026 - George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of... gene therapy chronic diseases rejuvenate development aging https://www.biospace.com/fda/life-threatening-liver-toxicity-triggers-fda-freeze-on-two-intellia-gene-therapy-studies Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies - BioSpace Oct 30, 2025 - The clinical hold comes days after Intellia voluntarily paused enrollment and dosing in the same two studies. life threatening gene therapy liver toxicity triggers https://www.biospace.com/fda/rockets-gene-therapy-wins-fda-greenlight-clearing-way-for-future-products Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products - BioSpace Mar 27, 2026 - While the accelerated approval unlocks only a small market opportunity for Rocket Pharmaceuticals, it will give the biotech a chance to prepare for future... gene therapy wins fda clearing way future products greenlight